Previous Article | Next Article 
Journal of Clinical Microbiology, January 2003, p. 368-372, Vol. 41, No. 1
0095-1137/03/$08.00+0 DOI: 10.1128/JCM.41.1.368-372.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Attempted Isolation of Nanobacterium sp. Microorganisms from Upper Urinary Tract Stones
Michel Drancourt,1 Véronique Jacomo,1 Hubert Lépidi,2 Eric Lechevallier,3 Vincent Grisoni,4 Christian Coulange,3 Edith Ragni,5 Claude Alasia,6 Bertrand Dussol,7 Yvon Berland,7 and Didier Raoult1*
Unité des Rickettsies, CNRS: UPRESA 6020, IFR48,1
Service de Microscopie Électronique, Faculté de Médecine, Université de la Méditerranée,6
Service d'Urologie et Transplantation Rénale,2
Service d'Urologie, Hôpital Salvator,3
Service d'Urologie, Hôpital Nord,4
Laboratoire d'Anatomopathologie, Hôpital de la Timone,5
Service de Néphrologie et d'Hémodialyse, Hôpital Sainte-Marguerite, Marseille, France7
Received 14 January 2002/
Returned for modification 17 May 2002/
Accepted 19 June 2002

ABSTRACT
A single team has reported isolation of nanobacteria in human
and bovine blood products, as well as, more recently, kidney
stones. This has raised controversy. To confirm the data, we
searched for nanobacteria from 10 aseptically removed upper
urinary tract (UUT) stones. We used scanning electronic microscopy
(SEM) with four stones and culture of stones on either 3T6 fibroblast
monolayers or liquid RPMI medium. Detection of nanobacteria
was made with a commercially available monoclonal antibody,
16S ribosomal DNA amplification with specific primers, and transmission
electronic microscopy (TEM) of inoculated cells. SEM showed
nanoparticles in four of four UUT stones similar to those recently
described. TEM of inoculated 3T6 cell monolayers has shown transient
intracytoplasmic vacuolar formations containing 200- to 500-nm
particles in 3 of 10 cell cultures. Gimenez staining, Hoechst
staining, and specific monoclonal immunofluorescence failed
to reveal nanobacteria. Finally, we could not grow
Nanobacterium sp. microorganisms by the techniques described. Although with
SEM, we observed nanoparticles morphologically similar to nanobacteria,
we failed to isolate
Nanobacterium sp. microorganisms in culture
and to prove the bacterial nature of these nanoparticles in
stones.

INTRODUCTION
Nanoparticles detected in various hot spring sediments (
7,
8)
and a Martian meteorite (
17) have been postulated to be bacterial
microorganisms on the basis of their morphological features.
In 1997, a Finnish team reported isolation of a hitherto-undescribed
bacterial species sharing morphological characteristics in common
with nanoparticles (
14), thereby providing some evidence in
support of earlier suspicions. These microorganisms were the
smallest described bacteria to date, with dimensions of 0.08
to 0.5 µm. Furthermore, these organisms were found to
produce a biofilm containing hydroxyl apatite or carbonate,
preventing their effective staining (
12). They were also isolated
from commercial serum used in cell culture (
11). Nanobacteria
have been detected thereafter in blood and blood products derived
from horses, as well as blood from human blood donors. Two strains,
one of
Nanobacterium sanguineum and the other of
Nanobacterium sp., were isolated from kidney stones and human and bovine sera,
respectively (
14). Phylogenetic analysis based on comparison
of 16S ribosomal DNA (rDNA) sequences has placed the nanobacteria
isolated from fetal calf serum into the
2 subgroup of
Proteobacteria (
14), closely related to
Thiobacillus, a water contaminant,
and
Agrobacterium and
Rhizobium, which are plant-associated
bacteria.
The controversy that surrounds this intriguing, apparently transmissible microorganism (1) particularly stems from the fact that isolation of nanobacteria has been reported by only one team and has not been confirmed by others (D. Y. Chang, T. W. Jarrett, L. R. Kavoussi, and J. B. Nelson, abstract from the 95th Annual Meeting of the American Urological Association, J. Urol. 161:249, 2000). Although a strain has been deposited in the German Collection of Microorganisms (DSM no. 5819-5821), it is not yet available to the scientific community. The aims of our study were to confirm the presence of nanoparticles in upper urinary tract (UUT) stones by morphological evidence with scanning electron microscopy (SEM) and to try to culture nanobacteria in cell cultures inoculated with UUT stones.

MATERIALS AND METHODS
Stones.
Ten UUT stones were aseptically removed from 10 French patients
who received 1 g of cefotaxime as antibioprophylaxis. Serum
was collected from these patients. All patients gave informed
consent. One fragment of each stone was preserved for culture
analysis, and the other fragment was used to determine its chemical
structure by Fourier-transformed infrared (IR) spectroscopy
according to the standard method for clinical use (
3).
Immunostaining and SEM.
Stones were manually ground and powdered with a Potter device. For immunostaining, stone fragments were deposited on a slide, air dried, heat fixed at 70°C for 10 min, rehydrated and blocked by soaking them in 2% fat dry milk-phosphate buffered saline (PBS), and then processed as previously described (3, 4, 12) with a commercial monoclonal mouse antibody (NanoBac Oy, Kuopio, Finland). For SEM, fragments collected from four stones were fixed with 2.5% glutaraldehyde (Sigma Chemicals, Saint-Louis, Mo.) for 20 min and then extensively washed with sterile PBS and rinsed in distilled water. Fixed material was dehydrated in a graded series of ethanol and dried in an EMscope CPD 750 critical point CO2 apparatus (Emscope Lab., Ashford, United Kingdom). The samples were placed in a JFC-1100 (JEOL, Tokyo, Japan) sputter coater for coating with gold-palladium. The UUT samples were examined with a JEOL 35CF SEM operated at 15 kV, and micrographs were recorded.
Cell coculture.
Stones were cocultured with 3T6 cells (ATTC CCL 96) in shell vials in Dulbecco-Vogt's modification of Eagle 's medium (DMEM) (Gibco, Paisley, United Kingdom) supplemented with 10% heat-inactivated fetal bovine serum (FBS). Four different batches were tested: Eurobio, batch 941338; Gibco, batches 40G4093I and 40G1891K; and Sigma, batch F2442. 3T6 cells were incubated for 24 h before inoculation of UUT stones. One part of each powdered stone was demineralized by incubation in 10 µl of 1 M HCl for 10 min at room temperature and then neutralized by addition of 10 µl of 1 M NaOH and 2 ml of DMEM-10% FBS. Finally, the suspension was filtered through a 0.22-µm-pore-size filter (Millipore, Saint-Quentin, France). The supernatant from each shell vial was discarded, and then 0.5 ml of the UUT stone suspension was inoculated onto the 3T6 monolayer, and the inoculated vials were centrifuged at 700 x g for 1 h and incubated at 37°C under 5% CO2. The presence of bacteria was monitored weekly by Gimenez staining (9) and Hoechst 33258 staining (Hoechst stain kit; Flow Laboratories, Ayrshire, United Kingdom) as previously described (14). Immunological detection of nanobacteria in cell cultures was attempted with a commercial monoclonal mouse antibody (NanoBac Oy, Kuopio, Finland) and by incorporating the patient's serum into an indirect immunofluorescence assay as previously described (18). Two powdered and demineralized stones were inoculated in parallel in 5 ml of RPMI 1640 with L-glutamine (Gibco) supplemented with 10% FBS in T-25 culture flasks and incubated at 37°C in a 5% CO2 environment for 4 weeks. Flasks were inspected macroscopically and microscopically weekly for biofilm formation and calcification. The presence of bacteria was monitored by Gimenez and Hoechst staining and by PCR-based detection of the universal 16S rRNA gene as previously described (6, 20) every week for 4 weeks. Transmission electron microscopy (TEM) of infected cells was performed at the 4th week. 3T6 cells cultured in DMEM with 10% FBS without inoculation of powdered stones under the same culture conditions were used as negative controls.

RESULTS
SEM.
The four UUT stones examined by SEM showed similar characteristics.
Spherical coccoid particles were observed, which were grouped
in coarse clusters and bound together to a mineral structure
(Fig.
1). These spherical units were similar in size and morphology.
The size of these particles varied between 200 and 300 nm, and
they appeared to have developed in stone cavities. Fourier IR
spectroscopy analysis indicated the stones consisted of cystine
or oxalate.
Cell coculture.
Gimenez staining of inoculated 3T6 cells and on inoculated RPMI
1640 medium failed to reveal nanobacteria after 1 week of culture
in any of the 10 stone samples (Table
1). However, after 3 weeks
of culture, two to three Gimenez-positive vacuolar inclusions
were observed in the cytoplasm of 10 to 20% of 3T6 cells in
9 of 10 inoculated cultures. After 5 weeks, 10 of 10 stone cultures
possessed these Gimenez-positive inclusions. Hoechst staining
was negative for all cultures and remained negative even after
6 weeks of culture (Table
1). Immunological detection with a
commercially available antinanobacterium monoclonal antibody
performed with two cultures failed to detect
Nanobacterium sp.
antigen after either 3 or 5 weeks of culture. Also, immunodetection
with the patient's serum failed to detect microorganisms in
10 of 10 inoculated 3T6 cell cultures. TEM showed intracytoplasmic
vacuolar formation containing 200- to 500-nm particles in 3
of 10 UUT stone cultures (Table
1). The morphology of nanoparticles
was coccoid, and they lay within vesicles in vacuolized 3T6
cells (Fig.
2). No calcification or biofilm formation was observed
in the two RPMI T-25 flasks inoculated with stones, and Gimenez
and Hoechst staining failed to reveal any microorganisms. PCR
incorporating the universal 16S rRNA gene primers failed to
produce an amplicon in 10 of 10 inoculated cell cultures and
in 2 of 2 inoculated RPMI flasks.

DISCUSSION
We have tried to demonstrate the presence of nanobacteria in
UUT stones by using SEM and culture. Despite previously reported
success for these approaches (
3,
12,
13), in our hands, only
SEM yielded any evidence for the presence of nanoparticles.
However, although we observed spherical nanoparticles grouped
in clusters binding to the mineral surface and cavities of UUT
stones, we saw no clear evidence to support a microbiological
nature for these structures. Immunological detection with a
commercially available anti-
Nanobacterium sp. monoclonal antibody
failed to detect nanobacteria as described by Kajander and colleagues
(
3,
4,
12). Although intracellular structures similar to nanoparticles
were transiently observed by TEM in 3T6 cells inoculated with
material derived from UUT stones (
12,
14), specific immunological
and molecular tools failed to confirm these cells contained
nanobacteria. Despite the fact that we strictly applied the
methods described by Kajander and coworkers, we failed to obtain
a nanobacterial culture from FBS and kidney stones. We therefore
wonder if there is a culture parameter not mentioned in publications
that could explain discrepancy between our results and those
previously reported. Alternatively, the formal possibility exists
that our specimen series simply did not contain any nanobacteria.
However, in an independent study (Chang et al., J. Urol.
161:249,
2000), 16 different renal calculi and 16 human serum samples
from patients with nephrolithiasis were been cultured. Detection
of nanobacteria was attempted with an enzyme-linked immunosorbent
assay (ELISA) and NanoDect-EIA kit (ACELL, Nano Oy, Kuopio,
Finland), as well as with 16S rDNA amplification with primers
derived from the published
Nanobacterium sp. sequences. No evidence
for the presence of the specific 16S rDNA sequence or nanobacterial
antigen in human kidney stones or serum specimen was found.
Although transferable biomineralization has been observed after
culture of human serum, human saliva, and dental plaque in DMEM
(
5), molecular examination of decalcified biofilms failed to
detect the nucleic acid or protein that would be expected from
growth of a living entity. Alternatively, initiation of biomineralization
by macromolecules and transfer by self-propagating microcrystalline
apatite was demonstrated. Cell cultures without addition of
antibiotics have been performed in our laboratory for the last
17 years. During this period of time, despite using numerous
cell lines and different batches of reagents, we have never
noticed formation of biofilms on plasticware surfaces. Furthermore,
detection of cocultivated microorganisms on cell cultures is
routinely performed by PCR with universal 16S rDNA primers (
6,
20), and direct immunofluorescence is routinely performed with
specific antibodies, and these approaches have never led to
the identification of
Nanobacterium sp. microorganisms. However,
transient Gimenez-positive inclusions are frequently observed
in our experience. The structures observed have been routinely
considered as artifacts, as are the structures we observed when
using TEM on UUT stone material-inoculated 3T6 cells.
In a recent study of patients with polycystic kidney disease (10), the authors found 23 of 31 kidney cystic fluids and 10 of 10 liver cyst fluids positive for Bartonella sp. antibody by immunofluorescence; reactivity between decalcified nanobacteria and hyperimmune serum to Bartonella henselae was observed. We have now performed 2,043 cell cultures of blood and biopsy samples obtained from serologically positive B. henselae and Bartonella quintana patients, using B. henselae and B. quintana polyclonal antibodies to detect positive cell cultures directly on coverslips (16). Not once have cross-reacting nanobacteria been encountered. Likewise, 100% of 22 cow serum samples demonstrated to react with the emerging Bartonella weisii species also reacted with N. sanguineum antigen (2). In three of these cow serum samples, B. weissii was indeed isolated. Based upon the respective 16S rDNA sequences, Bartonella and Nanobacterium spp. are members of the
2 subgroup of Proteobacteria and purportedly share cross-reacting epitopes. Also, Nanobacterium sp. 16S rDNA sequences share 97.8 to 99% similarity with those of Phyllobacterium myrsinacearum, another microorganism identified as a source of contaminating 16S rDNA in PCR studies (5, 19). These data may lead to the hypothesis of laboratory contamination as a possible explanation for discrepancies regarding demonstration of the presence of Nanobacterium sp. Despite our application of strict laboratory rules, we experienced cultured cell contamination by Methylobacterium, which is also a member of the
2 subgroup of Proteobacteria, from three different clinical samples (unpublished data). Culture contamination of clinical samples by the waterborne microorganism Afipia felis (15) has probably been responsible for the hypothesis that A. felis is the etiologic agent of cat scratch disease in humans. These bacterial species share the hospital water supply in the same ecological niche, and thus the hypothesis of contamination by waterborne bacteria cannot be ruled out.
Finally, in trying to confirm the data previously reported for nanobacteria, we have observed spherical particles adherent to UUT stones by using SEM. The morphology and size were compatible with nanobacteria, but we failed to culture these particles. The infectious nature of these particles has to be elucidated, and transmissibility from infected cell culture has to be proven. More investigations have to be done to determine whether the particles observed in UUT stones are bacteria. The availability of the nanobacterial strain for scientific investigators would be an important step in making progress in our research on nanobacteria.

ACKNOWLEDGMENTS
We acknowledge the technical assistance of Sandrine Zampa.

FOOTNOTES
* Corresponding author. Mailing address: Unité des Rickettsies, Faculté de Médecine, 27 Boulevard Jean Moulin, 13385 Marseille Cedex 5, France. Phone: 33 (0)4 91 83 55 17. Fax: 33 (0)4 91 83 03 90. E-mail:
Didier.Raoult{at}medecine.univ-mrs.fr.


REFERENCES
1 - Abbott, A. 1999. Battle lines drawn between "nanobacteria"researchers. Nature 401:105.[CrossRef][Medline]
2 - Breitschwerdt, E. B., S. Sontakke, A. Cannedy, S. I. Hancock, and J. M. Bradley. 2001. Infection with Bartonella weissii and detection of Nanobacterium antigens in a North Carolina beef herd. J. Clin. Microbiol. 39:879-882.[Abstract/Free Full Text]
3 - Ciftçioglu, N., M. Björklund, K. Kuorikoski, K. Bergström, and E. O. Kajander. 1999. Nanobacteria: an infectious cause for kidney stone formation. Kidney Int. 56:1893-1898.[CrossRef][Medline]
4 - Ciftçioglu, N., and E. O. Kajander. 1998. Interaction of nanobacteria with cultured mammalian cells. Physiopathology 4:259-270.
5 - Cisar, J. O., D. Q. Xu, J. Thompson, W. Swaim, L. Hu, and D. J. Kopecko. 2000. An alternative interpretation of nanobacteria-induced biomineralization. Proc. Natl. Acad. Sci. USA 97:11511-11515.[Abstract/Free Full Text]
6 - Drancourt, M., C. Bollet, A. Carlioz, R. Martellin, J.-P. Gayral, and D. Raoult. 2000. Evaluation of 16S ribosomal DNA sequence analysis of a large collection of environmental and clinical unidentifiable bacterial isolates. J. Clin. Microbiol. 38:3623-3630.[Abstract/Free Full Text]
7 - Folk, R. L. 1993. SEM imaging of bacteria and nanobacteria in carbonate sediments and rocks. J. Sediment. Petrol. 63:990-999.[Abstract/Free Full Text]
8 - Folk, R. L., and F. L. Lynch. 1997. The possible role of nanobacteria (dwarf bacteria) in clay-mineral diagenesis and the importance of careful sample preparation in high-magnification SEM study. J. Sediment. Res. 67:583-589.[Abstract/Free Full Text]
9 - Gimenez, D. F. 1964. Staining rickettsiae in yolk-sac cultures. Stain Technol. 39:135-140.[Medline]
10 - Hjelle, T. J., M. A. Miller-Hjelle, I. R. Poxton, O. Kajander, N. Ciftçioglu, M. L. Jones, R. C. Caughey, R. Brown, P. D. Millikin, and F. S. Darras. 2000. Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int. 57:2360-2374.[CrossRef][Medline]
11 - Kajander, E. O. August 1992. Culture and detection method for sterile-filterable autonomously replicating biological particles. U.S. patent 5,135,851.
12 - Kajander, E. O., and N. Ciftcioglu. 1998. Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc. Natl. Acad. Sci. USA 95:8274-8279.[Abstract/Free Full Text]
13 - Kajander, E. O., N. Ciftçioglu, M. A. Miller-Hjelle, and J. T. Hjelle. 2001. Nanobacteria: controversial pathogens in nephrolithiasis and polycystic kidney disease. Curr. Opin. Nephrol. Hypertens. 10:445-452.[CrossRef][Medline]
14 - Kajander, E. O., I. Kuronen, A. Pelttari, and N. Ciftçioglu. 1997. Nanobacteria from blood, the smallest culturable autonomously replicating agent on Earth, p. 420-428. In Instruments, methods, and missions for the investigation of extraterrestrial microorganisms. SPIE Proceedings Series, vol. 3111. Society of Photo-Optical Instrumentation Engineers, Washington, D.C.
15 - La Scola, B., and D. Raoult. 1999. Afipia felis in hospital water supply in association with free-living amoebae. Lancet 353:1330.[CrossRef][Medline]
16 - La Scola, B., and D. Raoult. 1999. Culture of Bartonella quintana and Bartonella henselae from human samples: a 5-year experience (1993 to 1998). J. Clin. Microbiol. 37:1899-1905.[Abstract/Free Full Text]
17 - McKay, D. S., E. K. Gibson, Jr., K. L. Thomas-Keprta, H. Vali, C. S. Romanek, S. J. Clemett, X. Chillier, C. R. Maechling, and R. N. Zare. 1996. Search for past life on Mars: possible relic biogenic activity in Martian meteorite ALH84001. Science 273:924-930.[Abstract/Free Full Text]
18 - Raoult, D., M.-L. Birg, B. La Scola, P.-E. Fournier, M. Enea, H. Lépidi, V. Roux, J.-C. Piette, F. Vandenesch, D. Vital-Durand, and T. Marrie. 2000. Cultivation of the bacillus of Whipple's disease. N. Engl. J. Med. 342:620-625.[Abstract/Free Full Text]
19 - Tanner, M. A., B. M. Goebel, M. A. Dojka, and N. R. Pace. 1998. Specific ribosomal DNA sequences from diverse environmental settings correlate with experimental contaminants. Appl. Environ. Microbiol. 64:3110-3113.[Abstract/Free Full Text]
20 - Weisburg, W. G., S. M. Barns, D. A. Pelletier, and D. J. Lane. 1991. 16S ribosomal DNA amplification for phylogenetic study. J. Bacteriol. 173:697-703.[Abstract/Free Full Text]
Journal of Clinical Microbiology, January 2003, p. 368-372, Vol. 41, No. 1
0095-1137/03/$08.00+0 DOI: 10.1128/JCM.41.1.368-372.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Martel, J., Young, J. D.-E
(2008). From the Cover: Purported nanobacteria in human blood as calcium carbonate nanoparticles. Proc. Natl. Acad. Sci. USA
105: 5549-5554
[Abstract]
[Full Text]
-
Bratos-Perez, M. A., Sanchez, P. L., Garcia de Cruz, S., Villacorta, E., Palacios, I. F., Fernandez-Fernandez, J. M., Di Stefano, S., Orduna-Domingo, A., Carrascal, Y., Mota, P., Martin-Luengo, C., Bermejo, J., San Roman, J. A., Rodriguez-Torres, A., Fernandez-Aviles, F., on behalf of Grupo AORTICA (Grupo de Estudio de la,
(2008). Association between self-replicating calcifying nanoparticles and aortic stenosis: a possible link to valve calcification. Eur Heart J
29: 371-376
[Abstract]
[Full Text]
-
Miyoshi, T., Iwatsuki, T., Naganuma, T.
(2005). Phylogenetic Characterization of 16S rRNA Gene Clones from Deep-Groundwater Microorganisms That Pass through 0.2-Micrometer-Pore-Size Filters. Appl. Environ. Microbiol.
71: 1084-1088
[Abstract]
[Full Text]
-
Miller, V. M., Rodgers, G., Charlesworth, J. A., Kirkland, B., Severson, S. R., Rasmussen, T. E., Yagubyan, M., Rodgers, J. C., Cockerill, F. R. III, Folk, R. L., Rzewuska-Lech, E., Kumar, V., Farell-Baril, G., Lieske, J. C.
(2004). Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves. Am. J. Physiol. Heart Circ. Physiol.
287: H1115-H1124
[Abstract]
[Full Text]
-
Aho, K., Kajander, E. O., Raoult, D.
(2003). Pitfalls in Detection of Novel Nanoorganisms. J. Clin. Microbiol.
41: 3460-3461
[Full Text]